Ontology highlight
ABSTRACT:
SUBMITTER: Tisi MC
PROVIDER: S-EPMC10405197 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature
Tisi Maria Chiara MC Moia Riccardo R Patti Caterina C Evangelista Andrea A Ferrero Simone S Spina Michele M Tani Monica M Botto Barbara B Celli Melania M Puccini Benedetta B Cencini Emanuele E Di Rocco Alice A Chini Claudio C Ghiggi Chiara C Zambello Renato R Zanni Manuela M Sciarra Roberta R Bruna Riccardo R Ferrante Martina M Pileri Stefano Alessandro SA Quaglia Francesca Maria FM Stelitano Caterina C Re Alessandro A Volpetti Stefano S Zilioli Vittorio Ruggero VR Arcari Annalisa A Merli Francesco F Visco Carlo C
Blood advances 20230801 15
The combination of rituximab, bendamustine, and low-dose cytarabine (R-BAC) has been studied in a phase 2 prospective multicenter study from Fondazione Italiana Linfomi (RBAC500). In 57 previously untreated elderly patients with mantle cell lymphoma (MCL), R-BAC was associated with a complete remission rate of 91% and 2-year progression-free survival (PFS) of 81% (95% confidence interval [CI], 68-89). Here, we report the long-term survival outcomes, late toxicities, and results of minimal residu ...[more]